This is a draft schedule. Presentation dates, times and locations may be subject to change.

440
Influence of Vaccination with a Combined Chemically Altered/Inactivated Bhv-1/BVD Vaccine or a Modified Live Vaccine on Reproductive Performance in Beef Cows and Heifers

Tuesday, July 11, 2017: 10:30 AM
314 (Baltimore Convention Center)
George A. Perry, Department of Animal Science, South Dakota State University, Brookings, SD
Thomas W. Geary, USDA-ARS Fort Keogh LARRL, Miles City, MT
Julie A. Walker, Department of Animal Science, South Dakota State University, Brookings, SD
Jerica J. J. Rich, Department of Animal Science, South Dakota State University, Brookings, SD
Emmalee J. Northrop, Department of Animal Science, South Dakota State University, Brookings, SD
Stephanie D. Perkins, Department of Animal Science, South Dakota State University, Brookings, SD
Christina L. Mogck, Department of Animal Science, South Dakota State University, Brookings, SD
Megan Van Emon, Montana State University, Bozeman, MT
Abigail L Zezeski, USDA-ARS Fort Keogh LARRL, Miles City, MT
Russell F. Daly, Department of Veterinary and Biomedical Sciences, South Dakota State University, Brookings, SD
Previous research has indicated that vaccination with a modified live BHV-1/BVD vaccine (MLV) has negative effects on AI conception rates when performed 30 d prior to AI. To further investigate vaccine effects on reproductive performance, a field trial was conducted on 10 herds of well-vaccinated cows and heifers (n=1565; all of which had been on a MLV vaccination program) to evaluate whether a MLV vaccine administered prebreeding would have negative impacts on conception rates compared to a combined chemically altered/inactivated BHV-1/BVD vaccine (CA/IV). Within herd, cows were blocked by parity and calving date and randomly assigned to receive one of the two treatments (MLV or CA/IV vaccine). Animals received a single (cows) or two injections (heifers) of either the MLV or CA/IV vaccine with the final injection occurring between 27 and 89 d prebreeding. All females were synchronized with the 7-d CO-Synch + CIDR protocol and inseminated (AI) at the appropriate time after CIDR removal (cows 60 to 66 hrs; heifers 52 to 56 hrs) and remained separated from bulls for at least 10 d after AI. Pregnancy success and fetal age were determined between d 34 and 86 after AI, and > 30 d after the breeding season. Data were analyzed using the GLIMMIX procedure in SAS with herd as a random variable. Conception rates to AI were greater in the CA/IV vaccine group compared to the MLV vaccine group (P = 0.05; 60% vs 52%). Furthermore, interval from vaccination with either vaccine until AI also influenced conception rates (P = 0.02). Animals vaccinated 27 to 30 d prebreeding and animals vaccinated 30 to 37 d prebreeding had similar (P = 0.98; 52% and 52%) conception rates; however, both were decreased compared to animals vaccinated 38 to 89 d prebreeding (P < 0.03; 64%). There was no treatment by interval interaction (P = 0.79). Furthermore, there was no effect of treatment (P = 0.18) or treatment by interval interaction (P = 0.17) on breeding season pregnancy rates. Days postpartum tended (P = 0.07) to influence conception rates with short postpartum cows (≤ 60 d) having decreased conception rates compared to cows that were further postpartum. In summary, vaccination of well-vaccinated beef cows and heifers with a MLV vaccine pre-breeding (28 to 89 d) decreased AI conception rates compared to a CA/IV vaccine.